Oncology PracticeProstate cancer racial disparity seen even in very-low-risk diseaseJuly 31, 2013Genitourinary Cancer
Oncology Practice'Decision aids' inform men but don’t alter prostate screening rate July 29, 2013Genitourinary Cancer
Oncology PracticeRadium-223 prolongs survival in metastatic prostate cancerJuly 17, 2013Genitourinary Cancer
Oncology PracticeAndrogen deprivation therapy linked to acute kidney injuryJuly 16, 2013Genitourinary Cancer
Oncology PracticeProlaris test eyed as predictor of prostate cancer outcomesJuly 12, 2013Genitourinary Cancer
The Journal of Community and Supportive OncologyEnzalutamide in castrate-resistant prostate cancer after chemotherapyJuly 3, 2013Genitourinary Cancer
Oncology PracticeDespite low-risk prostate cancer, high-tech treatment risesJune 25, 2013Genitourinary Cancer
Oncology PracticeGETUG 13: Dose-dense chemo is new standard for poor-risk germ cell tumorsJune 25, 2013Genitourinary CancerRare Diseases
Oncology PracticeTIP promising as first-line germ cell tumor therapyJune 24, 2013Genitourinary Cancer
Oncology PracticeNovel biomarker may measure prostate cancer aggressivenessMay 24, 2013Genitourinary Cancer
Oncology PracticeNo higher risk of cancer after 9 years of testosterone replacement therapyMay 24, 2013Genitourinary Cancer
The Journal of Community and Supportive OncologyUtilization of radiotherapy services by a palliative care unit: pattern and implicationMay 24, 2013Patient & Survivor CareBreast CancerGastroenterologyGenitourinary CancerHead & Neck/Thyroid CancersGastrointestinal Cancer
The Journal of Community and Supportive OncologyMalignant phyllodes tumor of the prostate and seminal vesicle: an unusual presentationMay 23, 2013Genitourinary CancerRare Diseases
